These independent CME activities are supported by educational grants from Bristol-Myers Squibb



    Hematology Mastery in
  Multiple Myeloma
  1. Course List
Chair
faculty image
Noopur Raje, MD
  • Director, Center for Multiple Myeloma
  • MGH Cancer Center
  • Massachusetts General Hospital
  • Boston, Massachusetts
  • Hematology Mastery in Multiple Myeloma is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the 2017 ASCO (American Society of Clinical Oncology) Annual Meeting, the Society of Hematologic Oncology (SOHO) Annual Meeting, and ASH 2017 – The 59th American Society of Hematology Annual Meeting and Exposition and poster presentations from ASH 2017 – The 59th American Society of Hematology Annual Meeting and Exposition.
  • Evaluate criteria that have been developed to assess treatment response in multiple myeloma and delineate how these criteria can be used to risk-stratify patients in clinical practice.
  • Formulate personalized treatment regimens that improve patient outcomes based on an understanding of the mechanism of action, efficacy, and safety profiles of current and emerging treatment options.
  • Target Audience

    This series of activities is designed for hematologists, oncologists, radiologists, primary care physicians, nurse practitioners, and other clinicians involved in the screening and treatment of patients with multiple myeloma.

     

    Activity Goal

    The goal of this program is to provide information and case studies at the point of care on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma.